Liver Transplantation
Treatment for Liver Cancer Due To Hepatitis B
Typical Dosage: procedure-based, immunosuppressants lifelong
Effectiveness
95%
Safety Score
25%
Clinical Trials
50
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
procedure-based, immunosuppressants lifelong
Time to Effect
immediate (tumor removal), long-term survival benefit
Treatment Duration
single surgery, lifelong immunosuppression
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15,000
Monitoring:$15,000
Side Effect Mgmt:$10,000
Total Annual:$40,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEICER
$150,000/QALY
QALYs Gained
8
Comparison vs Surgical Resection
Cost Difference
+$200,000/year
More expensive
QALY Difference
+1.00 QALYs
Better outcomes
Dominance
No dominance
Liver Transplantation Outcomes
for Liver Cancer Due To Hepatitis B
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+100%
Remission Rate
+100%
Common Side Effects
Surgical complications (bleeding, infection)
+15%
Organ rejection
+20%
Kidney dysfunction (due to immunosuppressants)
+30%
Increased infection risk
+40%
New-onset diabetes
+10%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov